GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

oprelvekin   Click here for help

GtoPdb Ligand ID: 6971

Synonyms: Neumega®
Approved drug Immunopharmacology Ligand
oprelvekin is an approved drug (FDA (1997))
Compound class: Peptide
Comment: This is a non-glycosylated, recombinant form of human IL-11 produced in E.coli. Oprelvekin is one amino acid shorter than the endogenous peptide, lacking the amino-terminal proline residue.
Immunopharmacology Comments
Oprelvekin is included in GtoImmuPdb because of its effects on platelet production.